Baseline clinical, resting echocardiographic characteristics of patients with diabetes compared with patients without diabetes
| Diabetes (n=96) | No diabetes (n=10) | p Value | |
|---|---|---|---|
| Clinical and anthropological characteristics | |||
| Age (years) | 56±9 | 50±7 | 0.058 |
| Male | 58 (60%) | 7 (70%) | 0.554 |
| Height (cm) | 168±9 | 172±11 | 0.127 |
| Weight (kg) | 94±25 | 83±18 | 0.148 |
| Body surface area (m2) | 2.08±0.29 | 1.98±0.276 | 0.304 |
| Body mass index (kg/m2) | 34±8 | 28±4 | 0.025 |
| Smoking n (%) | 13 (14%) | 1 (10%) | 0.753 |
| Hypertension n (%) | 71 (74%) | 2 (20%) | <0.001 |
| Dyslipidaemia n (%) | 77 (80%) | 4 (40%) | 0.004 |
| Family history CAD n (%) | 31 (32%) | 4 (40%) | 0.622 |
| Antiplatelet agent n (%) | 33 (34%) | 1 (10%) | 0.116 |
| β-blocker n (%) | 10 (10%) | 0 (0%) | 0.593 |
| Calcium channel blocker n (%) | 21 (22%) | 0 (0%) | 0.205 |
| ACE inhibitor n (%) | 38 (40%) | 0 (0%) | 0.013 |
| Angiotensin receptor blocker n (%) | 34 (35%) | 1 (10%) | 0.160 |
| Diuretics n (%) | 18 (19%) | 0 (0%) | 0.206 |
| Statin n (%) | 55 (57%) | 2 (20%) | 0.042 |
| Fenofibrate | 2 (2%) | 0 (0%) | 1.000 |
| MRC dyspnoea grade | 0.397 | ||
| 1 | 30 (31%) | 6 (60%) | |
| 2 | 50 (52%) | 4 (40%) | |
| 3 | 8 (8%) | 0 (0%) | |
| 4 | 8 (8%) | 0 (0%) | |
| 5 | 0 (0%) | 0 (0%) | |
| Resting left ventricular parameters | |||
| LV end-diastolic volume index (mL/m2) | 35±26 | 45±13 | 0.09 |
| LV end-systolic volume index (mL/m2) | 10±6 | 15±6 | 0.021 |
| Resting LV ejection fraction (%) | 70±11 | 66±6 | 0.116 |
| Septal s′ (cm/s) | 7.0±1.4 | 7.3±1.3 | 0.463 |
| Septal e′ (cm/s) | 6.7±1.7 | 8.6±2.0 | 0.002 |
| Septal E/e′ | 10.2±4.2 | 7.7±1.5 | <0.001 |
| Lateral s′ (cm/s) | 7.6±2.1 | 7.3±2.0 | 0.687 |
| Lateral e′ (cm/s) | 8.2±2.4 | 9.7±3.5 | 0.092 |
| Lateral E/e′ | 8.6±4.0 | 7.9±5.1 | 0.593 |
| LV mass index (g/m2) | 76±20 | 75±18 | 0.910 |
CAD, coronary artery disease; LV, left ventricular; MRC, Medical Research Council.